Analysts think IOVA stock price could increase by 201%
Nov 21, 2024, 12:26 PM
-9.34%
What does IOVA do
Iovance Biotherapeutics, based in San Carlos, California, specializes in cell therapies for cancer, focusing on its lead product, Amtagvi, for melanoma treatment. The company employs 557 people and went public in 2008.
15 analysts think IOVA stock price will increase by 200.74%. The current median analyst target is $24.48 compared to a current stock price of $8.14. The lowest analysts target is $10.10 and the highest analyst target is $35.70.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
